Molecular and structural insights into SARS-CoV-2 evolution: from BA.2 to XBB subvariants
Open Access
- 16 October 2024
- journal article
- review article
- Published by American Society for Microbiology in mBio
- Vol. 15 (10) , e0322023
Abstract
Due to the incessant emergence of various SARS-CoV-2 variants with enhanced fitness in the human population, controlling the COVID-19 pandemic has been challenging. Understanding how the virus enhances its fitness during a pandemic could offer valuable insights for more effective control of viral epidemics. In this manuscript, we review the evolution of SARS-CoV-2 from early 2022 to the end of 2023—from Omicron BA.2 to XBB descendants. Focusing on viral evolution during this period, we provide concrete examples that SARS-CoV-2 has increased its fitness by enhancing several functions of the spike (S) protein, including its binding affinity to the ACE2 receptor and its ability to evade humoral immunity. Furthermore, we explore how specific mutations modify these functions of the S protein through structural alterations. This review provides evolutionary, molecular, and structural insights into how SARS-CoV-2 has increased its fitness and repeatedly caused epidemic surges during the pandemic.Keywords
Funding Information
- AMED | ASPIRE Program (JP24jf0126002)
- AMED | SCARDA Japan Initiative for World-leading Vaccine Research and Development Centers "UTOPIA" (JP243fa627001)
- AMED | SCARDA Program on R&D of new generation vaccine including new modality application (JP243fa727002)
- AMED | SCARDA Kyoto University Immunomonitoring Center (JP223fa627009)
- AMED | SCARDA Hokkaido University Institute for Vaccine Research and Development (JP223fa627005)
- AMED | BINDS (JP17am0101093 and JP22ama121037)
- AMED | CREST (JP21fk0108463 and JP22gm1810004)
- AMED | Research Program on Emerging and Re-emerging Infectious Diseases (JP24fk0108690)
- AMED | Research Program on Emerging and Re-emerging Infectious Diseases (JP22fk0108572 and JP24wm0225025)
- JST | PRESTO (JPMJPR22R1)
- JSPS | KAKENHI Fund for the Promotion of Joint International Research (JP23K20041)
- JSPS | KAKENHI Grant-in-Aid for Early-Career Scientists (JP23K14526)
- JSPS | KAKENHI Grant-in-Aid for Scientific Research A (JP24H00607)
- JSPS | KAKENHI Grant-in-Aid for Challenging Research (JP20K20596)
- JSPS | KAKENHI Grant-in-Aid for The Scientific Research on Innovative Areas and International Group (JP20H05873)
- JSPS | Core-to-Core Program (JPJSCCA20240006)
- Mitsubishi UFJ Financial Group, Inc. Vaccine Development Grant (NA)
- International Joint Research Project of the Institute of Medical Science, the University of Tokyo (NA)
- The Cooperative Research Program (Joint Usage/Research Center program) of Institute for Life and Medical Sciences, Kyoto University (NA)
- Hokkaido University Biosurface project (NA)
- The Naito Foundation (NA)
- Takeda Science Foundation (NA)
This publication has 72 references indexed in Scilit:
- A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Cell Reports, 2022
- Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spikeCell Reports, 2022
- Virological characteristics of the SARS-CoV-2 Omicron BA.2 spikeCell, 2022
- Structural and functional impact by SARS-CoV-2 Omicron spike mutationsCell Reports, 2022
- Cryo-EM structure of the SARS-CoV-2 Omicron spikeCell Reports, 2022
- Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 OmicronCell, 2022
- Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concernCell Reports, 2022
- The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistanceCell Reports, 2021
- D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 JunctionCell Reports, 2021
- Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein VariantCell, 2020